|
|
|
Lab Dept:
|
Coagulation
|
Test Name:
|
FACTOR XII ASSAY
|
General Information
|
Lab Order Codes:
|
F12
|
Synonyms:
|
Hageman Factor; XIIa; Factor XII Activity, Factor 12
|
CPT Codes:
|
85280 - Clotting factor XII (Hageman)
|
Test Includes:
|
Factor XII level reported as a %.
|
Logistics
|
Test Indications:
|
Useful for the detection of a single factor congenital homozygous or heterozygous deficiency.
|
Lab Testing Sections:
|
Coagulation
|
Phone Numbers:
Minneapolis:
Saint Paul:
|
|
612-813-6280
|
651-220-6550
|
Test Availability:
|
Daily, 24 hours
|
Turnaround Time:
|
4 hours
|
Special Instructions:
|
Patient should not be receiving heparin. If so, this should be noted on the request form. Heparin therapy can affect certain coagulation factors or assays, preclude their performance, or cause spurious results. Indicate when specimen is drawn from a line or a heparin lock. Deliver immediately to the laboratory.
|
Specimen
|
Specimen Type:
|
Whole blood
|
Container:
|
Light Blue top (Buffered Na Citrate 3.2%) tube
|
Draw Volume:
|
2.7 mL blood
|
Processed Volume:
|
0.9 mL plasma
|
Collection:
|
Patients with hematocrit levels of >55% must have a special tube made to adjust for the hematocrit. Contact the laboratory for special tube. Mix thoroughly by gentle inversion.
|
Special Processing:
|
Lab Staff: Spin sample collected in blue top tube(s) for 5 minutes on the Stat Spin centrifuge, remove plasma and transfer to a 4 ml BCS sample cup(s), spin remaining plasma again for 5 minutes in the Stat Spin Centrifuge. Transfer plasma to new BCS sample cup(s) for analysis (as specifically stated in each procedure) leaving approximately 200 mcL in the bottom of the original cup to discard.
|
Patient Preparation:
|
Avoid heparin therapy for two days prior to the test.
|
Sample Rejection:
|
Improper tube; clotted samples; underfilled tubes; mislabeled or unlabeled specimens
|
Interpretive
|
Reference Range:
|
Age
|
Range
|
0 – 1 day:
|
33 – 73%
|
2 – 5 days
|
29 – 65%
|
6 – 30 days:
|
33 – 65%
|
31 – 90 days
|
46 – 88%
|
91 – 180 days:
|
58 – 96%
|
6 months – 5 years:
|
64 – 129%
|
6 – 10 years:
|
60 – 140%
|
11 – 16 years:
|
34 – 137%
|
>16 years:
|
52 – 164%
|
Critical Values:
|
N/A
|
Limitations:
|
Interpretation of the results may be limited if patient is receiving anticoagulant therapy or if test is done more then 2 hours after collection.
|
Methodology:
|
Thromboplastin clotting time correction of Factor 12 deficient plasma. Patient dilutions are compared to a known set of standard dilutions and a percentage is determined.
|
Contraindications:
|
Patient on anticoagulant therapy.
|
References:
|
Harmening DH (1997) Clinical Hematology and Fundamentals of Hemostasis
|
Andrew M et al (1987) Development of the Human Coagulation System in the Healthy Full-Term Infant, Blood 70:165-72
|
Andrew M et al (1988) Development of the Human Coagulation System in the Healthy Premature Infant, Blood 72:1651-57
|
Andrew M et al (1992) Development of the Human Coagulation System During Childhood, Blood 80:1998-2005
|
Updates:
|
5/24/2010: Tubing of patient specimens is no longer prohibited.
12/15/2010: Processing information updated.
|
